November 17, 2023 — DeepSight Technology, a pioneering force in medical innovation, is thrilled to announce its groundbreaking NeedleVue solution. This state-of-the-art ultrasound-guided needle technology ushers in a new era of precision and safety in the field of directed interventional tool guidance, a domain grappling with complexities for several decades.
DeepSight’s proprietary NeedleVue solution marries innovative sensor technology with most interventional devices, facilitating real-time verification of placement and significantly reducing procedural guesswork. Conventional technologies often present challenges such as laborious calibration processes, decreased sensitivity, and the necessity for precise angles of incidence. NeedleVue delivers improvement across the board with its omnidirectional functionality at any plausible ultrasound depth, enhancing functionality and ease-of-use in a true "plug-and-play" solution.
Nader Sadrzadeh, the Chief Executive Officer at DeepSight Technology, shared his excitement: "NeedleVue not only signifies a monumental leap in the evolution of interventional tool guidance but also substantiates our steadfast commitment to ensuring procedural success - benefiting patients, clinicians, and healthcare providers alike. In a reality where procedural confidence is paramount, our solution stands out as a beacon of precision and reliability, effortlessly aligning with the multifaceted demands of modern healthcare."
Noteworthy advantages of the NeedleVue solution include:
- Unparalleled Precision: Achieving confident results by eliminating guesswork and ensuring verifiable placement in real-time.
- Enhanced Usability: A plug-and-play system that eliminates the need for complicated setups or extensive training.
- Versatility: Omnifunctionality at any ultrasound depth, broadening the scope of its applicability across various medical scenarios.
DeepSight’s NeedleVue delineates a clear paradigm shift in needle guidance technology by delivering real-time, precision needle tracking that is as portable as it is easy to use. The technology comes as a breath of fresh air in an era where healthcare providers are in pursuit of combining operational efficacy with optimized patient outcomes.
DeepSight Technology will be presenting NeedleVue at the upcoming Radiological Society of North America (RSNA) from November 26-30, 2023, providing a comprehensive insight into how this technology is poised to reshape and revolutionize the future of interventional procedures. This presentation will be available to limited audiences (specifically those who have executed a Non-Disclosure Agreement).
For more information: www.deepsight.com
April 15, 2026 
